474 related articles for article (PubMed ID: 27620165)
1. Vasodilator-Stimulated Phosphoprotein (VASP)-dependent and -independent pathways regulate thrombin-induced activation of Rap1b in platelets.
Benz PM; Laban H; Zink J; Günther L; Walter U; Gambaryan S; Dib K
Cell Commun Signal; 2016 Sep; 14(1):21. PubMed ID: 27620165
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets.
Wentworth JK; Pula G; Poole AW
Biochem J; 2006 Jan; 393(Pt 2):555-64. PubMed ID: 16197368
[TBL] [Abstract][Full Text] [Related]
3. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function.
Aszódi A; Pfeifer A; Ahmad M; Glauner M; Zhou XH; Ny L; Andersson KE; Kehrel B; Offermanns S; Fässler R
EMBO J; 1999 Jan; 18(1):37-48. PubMed ID: 9878048
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole synergizes with nitric oxide to prolong inhibition of thrombin-induced platelet shape change.
Jensen BO; Kleppe R; Kopperud R; Nygaard G; Døskeland SO; Holmsen H; Selheim F
Platelets; 2011; 22(1):8-19. PubMed ID: 20958117
[TBL] [Abstract][Full Text] [Related]
5. A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.
Lee HS; Kim SD; Lee WM; Endale M; Kamruzzaman SM; Oh WJ; Cho JY; Kim SK; Cho HJ; Park HJ; Rhee MH
Eur J Pharmacol; 2010 Feb; 627(1-3):85-91. PubMed ID: 19913011
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase A mediates inhibition of the thrombin-induced platelet shape change by nitric oxide.
Jensen BO; Selheim F; Døskeland SO; Gear AR; Holmsen H
Blood; 2004 Nov; 104(9):2775-82. PubMed ID: 15265792
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition.
Horstrup K; Jablonka B; Hönig-Liedl P; Just M; Kochsiek K; Walter U
Eur J Biochem; 1994 Oct; 225(1):21-7. PubMed ID: 7925440
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice.
Hauser W; Knobeloch KP; Eigenthaler M; Gambaryan S; Krenn V; Geiger J; Glazova M; Rohde E; Horak I; Walter U; Zimmer M
Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8120-5. PubMed ID: 10393958
[TBL] [Abstract][Full Text] [Related]
9. A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans.
Li Z; Ajdic J; Eigenthaler M; Du X
Blood; 2003 Jun; 101(11):4423-9. PubMed ID: 12576312
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
11. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
Eigenthaler M; Nolte C; Halbrügge M; Walter U
Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
13. Nobiletin, a citrus flavonoid, activates vasodilator-stimulated phosphoprotein in human platelets through non-cyclic nucleotide-related mechanisms.
Jayakumar T; Lin KC; Lu WJ; Lin CY; Pitchairaj G; Li JY; Sheu JR
Int J Mol Med; 2017 Jan; 39(1):174-182. PubMed ID: 27959381
[TBL] [Abstract][Full Text] [Related]
14. Off-target effect of the Epac agonist 8-pCPT-2'-O-Me-cAMP on P2Y12 receptors in blood platelets.
Herfindal L; Nygaard G; Kopperud R; Krakstad C; Døskeland SO; Selheim F
Biochem Biophys Res Commun; 2013 Aug; 437(4):603-8. PubMed ID: 23850619
[TBL] [Abstract][Full Text] [Related]
15. The role of adenosine diphosphate mediated platelet responsiveness for the stability of platelet integrity in citrated whole blood under ex vivo conditions.
Koessler J; Schwarz M; Weber K; Etzel J; Koessler A; Boeck M; Kobsar A
PLoS One; 2017; 12(11):e0188193. PubMed ID: 29155852
[TBL] [Abstract][Full Text] [Related]
16. The thrombin inhibitors hirudin and Refludan(®) activate the soluble guanylyl cyclase and the cGMP pathway in washed human platelets.
Kobsar A; Koessler J; Kehrer L; Gambaryan S; Walter U
Thromb Haemost; 2012 Mar; 107(3):521-9. PubMed ID: 22234363
[TBL] [Abstract][Full Text] [Related]
17. Platelet rap1B phosphorylation is a sensitive marker for the action of cyclic AMP- and cyclic GMP-increasing platelet inhibitors and vasodilators.
Grünberg B; Kruse HJ; Negrescu EV; Siess W
J Cardiovasc Pharmacol; 1995 Apr; 25(4):545-51. PubMed ID: 7596121
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation of the guanine-nucleotide-exchange factor CalDAG-GEFI by protein kinase A regulates Ca(2+)-dependent activation of platelet Rap1b GTPase.
Guidetti GF; Manganaro D; Consonni A; Canobbio I; Balduini C; Torti M
Biochem J; 2013 Jul; 453(1):115-23. PubMed ID: 23600630
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet effects of caffeic acid due to Ca(2＋) mobilizationinhibition via cAMP-dependent inositol-1, 4, 5-trisphosphate receptor phosphorylation.
Lee DH; Kim HH; Cho HJ; Bae JS; Yu YB; Park HJ
J Atheroscler Thromb; 2014; 21(1):23-37. PubMed ID: 24088646
[TBL] [Abstract][Full Text] [Related]
20. Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein.
Russo I; Del Mese P; Doronzo G; De Salve A; Secchi M; Trovati M; Anfossi G
Clin Chem; 2007 Jun; 53(6):1053-60. PubMed ID: 17463178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
